1.Quantitative expression and localization of cysteine and aspartic proteases in human abdominal aortic aneurysms.
Fabian LOHOEFER ; Christian REEPS ; Christina LIPP ; Martina RUDELIUS ; Felix HAERTL ; Edouard MATEVOSSIAN ; Alma ZERNECKE ; Hans Henning ECKSTEIN ; Jaroslav PELISEK
Experimental & Molecular Medicine 2014;46(5):e95-
Cysteine and aspartic proteases possess high elastolytic activity and might contribute to the degradation of the abdominal aortic aneurysm (AAA) wall. The aim of this study was to analyze, in detail, the proteases (cathepsins B, D, K, L and S, and inhibitor cystatin C) found in human AAA and healthy aortic tissue samples. The vessel walls from AAA patients (n=36) and nonaneurysmal aortae (n=10) were retrieved using conventional surgical repair and autopsy methods. Serum samples from the same AAA patients and 10 healthy volunteers were also collected. Quantitative expression analyses were performed at the mRNA level using real-time reverse transcriptase-PCR (RT-PCR). Furthermore, analyses at the protein level included western blot and immunoprecipitation analyses. Cellular sources of cysteine/aspartic proteases and cystatin C were identified by immunohistochemistry (IHC). All cysteine/aspartic proteases and cystatin C were detected in the AAA and control samples. Using quantitative RT-PCR, a significant increase in expression was observed for cathepsins B (P=0.021) and L (P=0.018), compared with the controls. Cathepsin B and cystatin C were also detected in the serum of AAA patients. Using IHC, smooth muscle cells (SMCs) and macrophages were positive for all of the tested cathepsins, as well as cystatin C; in addition, the lymphocytes were mainly positive for cathepsin B, followed by cathepsins D and S. All cysteine/aspartic proteases analyzed in our study were detected in the AAA and healthy aorta. The highest expression was found in macrophages and SMCs. Consequently, cysteine/aspartic proteases might play a substantial role in AAA.
Aged
;
Aorta/enzymology
;
Aortic Aneurysm, Abdominal/*enzymology
;
Aspartic Acid Proteases/genetics/*metabolism
;
Case-Control Studies
;
Cathepsins/genetics/metabolism
;
Cysteine Proteases/genetics/*metabolism
;
Humans
;
Lymphocytes/enzymology
;
Macrophages/enzymology
;
Middle Aged
;
Myocytes, Smooth Muscle/enzymology
;
RNA, Messenger/genetics/metabolism
2.Enhanced expression of cathepsin L in metastatic bone tumors.
In Chul PARK ; Soo Yong LEE ; Dae Geun JEON ; Jong Seok LEE ; Chang Sun HWANG ; yungB Gap HWANG ; Seung Hoon LEE ; Weon Seon HONG ; Seok Il HONG
Journal of Korean Medical Science 1996;11(2):144-148
Cathepsin L is a kind of cystein proteases which are known to facilitate the invasion and metastasis of tumor cells by degrading the components of basement membrane and extracellular matrix. This study was undertaken to investigate the expression of cathepsin L by Northern blot analysis with radiolabeled cDNA specific for cathepsin L in six normal tissues, two osteosarcoma cell lines, MG-63 and Saos-2, six primary bone tumors and six metastatic bone tumors. In six normal tissues, the highest level of cathepsin L was expressed in liver with the descending order of liver > lung > thymus > ovary > kidney > esophagus. One of the two osteosarcoma cell lines established from the primary sites expressed a high level of cathepsin L mRNA. Out of six primary bone tumors, three (50%) expressed cathepsin L mRNA, while all (100%) of six metastatic bone tumors expressed the mRNA. These results demonstrating the higher frequency of expression of cathepsin L in metastatic bone tumors suggest that cathepsin L may participate in tumor invasion and metastasis.
Adolescent
;
Adult
;
Bone Neoplasms/*genetics/*secondary
;
Case-Control Studies
;
Cathepsins/*metabolism
;
Cysteine Endopeptidases/*metabolism
;
Female
;
*Gene Expression Regulation, Neoplastic
;
Human
;
Male
;
Middle Age
;
Neoplasm Invasiveness/genetics
;
Neoplasm Metastasis/genetics
;
Osteosarcoma/genetics
;
RNA, Messenger/metabolism
;
Support, Non-U.S. Gov't
;
Tumor Cells, Cultured
3.Effect of jianpi-jiedu formula on tumor angiogenesis-relevant genes expression in colorectal cancer.
Dan MAO ; Sanlin LEI ; Jin'an MA ; Li SHI ; Shaofan ZHANG ; Jianhua HUANG ; Xinyi LIU ; Dengfeng DING ; Yingjin ZHANG ; Lei FENG ; Sifang ZHANG
Journal of Central South University(Medical Sciences) 2016;41(12):1297-1304
To investigate the effect of the jianpi-jiedu formula (JPJD) on the expression of angiogenesis-relevant genes in colon cancer.
Methods: Crude extract was obtained from JPJD by water extract method. The effect of JPJD crude extract on colon cancer cell proliferation capacity was determined by MTT assays. The IC50 value was calculated by GraphPad Prism5 software. Affymetrix gene expression profiling chip was used to detect significant differences in expressions of genes after JPJD intervention, and pathway enrichment analysis was performed to analyze the differentially expressed genes. Ingenuity Pathway Analysis software was applied to analyze differentially expressed genes relevant to tumor angiogenesis based on mammalian target of rapamycin (mTOR) signaling pathway and then the network diagram was built. Western blot was used to verify the protein levels of key genes related to tumor angiogenesis.
Results: JPJD crud extract inhibited the proliferation capacity in colon cancer cells. The IC50 values in 24, 48, and 72 hours after treatment were 13.060, 9.646 and 8.448 mg/mL, respectively. The results of chip showed that 218 genes significantly upgraded, and 252 genes significantly downgraded after JPJD treatment. Most of the genes were related to the function of biosynthesis, metabolism, cell apoptosis, antigen extraction, angiogenesis and so on. There were 12 differentially expressed angiogenesis genes. IPA software analysis showed that the JPJD downregulated expression of sphingomyelin phosphodiesterase 3 (SMPD3), VEGF, vascular endothelial growth factor A (VEGFA), integrin subunit alpha 1 (ITGA1), cathepsin B (CTSB), and cathepsin S (CTSS) genes, while upregulated expressions of GAB2 and plasminogen activator, urokinase receptor (PLAUR) genes in the colorectal cancer cell. Western blot results demonstrated that JPJD obviously downregulated expressions of phospho-mTOR (P-mTOR), signal transducer and activator of transcription 3 (STAT3), hypoxia inducible factor-1α (HIF-1α), and VEGF proteins, while obviously upregulated the level of phospho-P53 (P-P53) protein.
Conclusion: JPJD may inhibit colorectal tumor angiogenesis through regulation of the mTOR-HIF-1α-VEGF signal pathway.
Animals
;
Blotting, Western
;
Cathepsin B
;
drug effects
;
metabolism
;
Cathepsins
;
drug effects
;
metabolism
;
Cell Line, Tumor
;
drug effects
;
Colorectal Neoplasms
;
blood supply
;
genetics
;
Down-Regulation
;
Drugs, Chinese Herbal
;
pharmacology
;
Gene Expression Profiling
;
methods
;
Humans
;
Hypoxia-Inducible Factor 1, alpha Subunit
;
drug effects
;
metabolism
;
Integrin alpha Chains
;
drug effects
;
metabolism
;
Neovascularization, Pathologic
;
genetics
;
Receptors, Urokinase Plasminogen Activator
;
drug effects
;
metabolism
;
STAT3 Transcription Factor
;
drug effects
;
metabolism
;
Signal Transduction
;
Sphingomyelin Phosphodiesterase
;
drug effects
;
metabolism
;
TOR Serine-Threonine Kinases
;
drug effects
;
metabolism
;
Tumor Suppressor Protein p53
;
drug effects
;
metabolism
;
Up-Regulation
;
Vascular Endothelial Growth Factor A
;
drug effects
;
metabolism